Quarry LP’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6K Buy
+6
New +$1.4K ﹤0.01% 1758
2026
Q1
Sell
-576
Closed -$123K 1444
2025
Q4
$123K Sell
576
-2,594
-82% -$536K 0.02% 369
2025
Q3
$630K Buy
3,170
+170
+6% +$31.7K 0.14% 112
2025
Q2
$518K Sell
3,000
-300
-9% -$48.9K 0.11% 157
2025
Q1
$514K Buy
3,300
+2,600
+371% +$371K 0.11% 163
2024
Q4
$96.4K Buy
+700
New +$92K 0.01% 452
2024
Q3
Sell
-2,500
Closed -$341K 1633
2024
Q2
$341K Buy
2,500
+1,800
+257% +$245K 0.1% 109
2024
Q1
$106K Buy
+700
New +$99.9K 0.02% 232

Other funds holding ASND

Quarry LP's ASND Position: Q2 2026 in Review

Quarry LP opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 6 shares worth $1.6K. The stake represents ﹤0.01% of the portfolio and ranks #1758 among its holdings. This is a return to the name: Quarry LP previously reported a position in ASND as recently as Q4 2025.

Quarry LP first reported a position in ASND in Q1 2024 and has held it in 8 quarters since. The position peaked at $630K in Q3 2025. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Quarry LP held 6 shares of Ascendis Pharma A/S worth $1.6K as of Q2 2026.
  • Ascendis Pharma A/S was a new Quarry LP position in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1758 holding.
  • Quarry LP first reported a position in Ascendis Pharma A/S in Q1 2024 and has held it in 8 quarters since.
  • Quarry LP's Ascendis Pharma A/S position peaked at $630K in Q3 2025.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.